Background: Chloral hydrate use in children has fallen out of favor as a primary sedation agent due to unpredictable sedation properties, prolonged recovery times, and the potential for severe adverse effects. Utilization declined across the nation after commercial production of the oral solution was discontinued in 2012. Despite the growing use of alternative sedatives, many pharmacies continue to compound chloral hydrate solution from raw ingredients. This compounding process is associated with more frequent sedation failures and requires the ingestion of larger suspension volumes. Fatalities associated with chloral hydrate use continue to occur.
